Axsome Therapeutics Inc (NASDAQ:AXSM)

45.35
Delayed Data
As of Oct 03
 +0.71 / +1.59%
Today’s Change
20.63
Today|||52-Week Range
71.98
+20.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.8B

Company Description

Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Contact Information

Axsome Therapeutics, Inc.
22 Cortlandt Street
New York New York 10007
P:(212) 332-3241
Investor Relations:

Employees

Shareholders

Other institutional34.83%
Individual stakeholders22.61%
Mutual fund holders19.39%

Top Executives

Herriott TabuteauChairman & Chief Executive Officer
Mark L. JacobsonChief Operating Officer
Nick PizzieChief Financial Officer
Joseph Debrah-AffulController
Amanda JonesSenior Vice President-Clinical Development